The Vaccine Adjuvant Compendium (VAC) was launched in 2021 by the NIAID Division of Allergy, Immunology, and Transplantation (DAIT) to foster collaborations between NIAID-supported adjuvant researchers and the broader scientific community. The VAC displays adjuvant characteristics or metadata defined through NIAID-supported adjuvant studies to help vaccine developers identify suitable adjuvants for various vaccine indications, including immune-mediated and infectious diseases. In addition, the VAC welcomes the inclusion of adjuvant metadata generated by other research programs.
Available Resources
-
Database of adjuvant characteristics or metadata defined through NIAID-supported adjuvant studies.
-
VAC welcomes the inclusion of adjuvant metadata generated by other research programs.
Learn more about how to use and access VAC or go directly to the Vaccine Adjuvant Compendium (VAC) website.